| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9960020 | Journal of the American College of Cardiology | 2005 | 7 Pages |
Abstract
Ambrisentan appears to improve exercise capacity, symptoms, and hemodynamics in patients with PAH. The incidence and severity of liver enzyme abnormalities appear to be low.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nazzareno MD, David MD, Ronald MD, Gérald MD, Michael D. MD, Anne M. MD, Adaani E. MD, Diane MD, Robert MD, Shelley MD, PhD, Horst MD, Lewis J. MD,